RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FERRAù F
Collezione AO Cuneo

Items : 5

An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer. in Cells / Cells. 2022 Oct 10;11(19):3176. doi: 10.3390/cells11193176.

2022
AO Cuneo
AOU Novara

De Cecco L; Licitra L; Bossi P; Ferraù F; Rinaldi G; Vaccher E; Moretti G; Denaro N; Caponigro F; Rocca MC; Secondino S; Moro C; Sponghini A; Caldara A; Ferrari D; Vecchio S; Lenoci D; Pistore F; Miceli R; Canevari S; Cavalieri S; Carenzo A; Serafini MS;

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study. in Breast cancer research and treatment / Breast Cancer Res Treat. 2021 Dec;190(3):415-424. doi: 10.1007/s10549-021-06375-5. Epub 2021 Sep 21.

2021
ASL Asti
AO Cuneo
AOU Città della Salute di Torino

Clivio L; Spadaro P; Di Mauro P; Cogliati V; Capici S; Vici P; Valenza R; Valerio MR; Turletti A; Tralongo P; Toniolo D; Taverniti C; Scognamiglio G; Schintu MG; Sarobba MG; Saracchini S; Santini D; Riccardi F; Putzu C; Sarti S; Musolino A; Nicolini M; Marchetti P; Leonardi V; Grassadonia A; Giovanardi F; Gianni L; Generali D; Gebbia V; et alii...

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2019 Jul 1;25(13):3839-3846. doi: 10.1158/1078-0432.CCR-18-3661. Epub 2019 Apr 9.

2019
ASL Cuneo 2
AO Cuneo

Sternberg CN; Caserta C; Cartenì G; Fornarini G; Verusio C; Scoppola A; Crinò L; Frassoldati A; Mini E; Marchetti P; Ortega C; Bidoli P; Ferraù F; Mitterer M; Sabbatini R; Bearz A; Buti S; Basso U; Procopio G; De Giorgi U; Giannarelli D;

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. in Breast (Edinburgh, Scotland)

2019
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Città di Torino
ASL Vercelli

Valenza R; Clivio L; Torri V; Vici P; Valerio MR; Turletti A; Tralongo P; Toniolo D; Spadaro P; Taverniti C; Scognamiglio G; Saracchini S; Sarobba MG; Schintu MG; Santini D; Riccardi F; Nicolini M; Putzu C; Marchetti P; Melegari E; Musolino A; Leonardi V; Grassadonia A; Gianni L; Giovanardi F; Gebbia V; Generali D; Garrone O; Fontana A; et alii...

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Nov 1;28(11):2820-2826. doi: 10.1093/annonc/mdx439.

2017
AOU Città della Salute di Torino
AO Cuneo
AOU Novara

Licitra L; Hollander L; Tettamanzi F; Ferrau F; Nolè F; Lo Vullo S; Rinaldi G; Caldara A; Sponghini A; Vaccher E; Moro C; Airoldi M; Caponigro F; Moretti G; Denaro N; Vecchio S; Ferrari D; Locati LD; Miceli R; Bossi P;